Pharmafile Logo

Webinar: Ensuring an actionable segmentation

March 31, 2015 |  

One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.

One of the most consistent issues researchers face with segmentation is ensuring that it is actionable. Even the best constructed and well observed segmentation solution will fall down if people within your company don’t adopt it, and the most detailed and comprehensive (and expensive) segmentation is of no use if it isn’t implemented.

In this webinar, quantitative experts Duncan Munro and Jennifer Redfearn, utilise knowledge and experience garnered from more than 15 years of conducting global segmentations for pharma, to explore the following key segmentation challenges:

  • Conducting global segmentations
    The benefits and potential pitfalls of conducting global segmentation research
  • Encouraging internal buy-in
    Examining the best techniques to ensure that a segmentation is adopted by key internal stakeholders.
  • Ensuring sales force execution
    Identifying the key challenges that prevent successful execution and explore the ways in which researchers can overcome these issues and ensure an actionable segmentation   
  • Answer your segmentation questions

To view this webinar please visit http://bit.ly/1C4QKwL

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Eyeforpharma Real World Evidence Conference Round up 2018

Earlier this month, APAC Director Pei Li Teh attended Asia’s 11th Eyeforpharma conference in Tokyo, Japan with a focus on Real World Evidence (RWE)This year has seen a turning point...

EphMRA Annual Conference 2018

Visit us on stand number 20

Connected Patients – Adopting a patient-centric approach in emerging markets

The concept of patient centricity and putting the patient at the heart of care is being widely adopted by the healthcare industry – the general consensus being that it’s going...

Combination therapies in oncology: The benefits of integrated insights

14 June 2018 11am EDT | 8am PDT | 4pm BST | 5pm CE

Intellus round up 2018

Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia

Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

We are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in London for our collaborative market research...

How published research underpinned a cancer therapy awareness campaign

Our client markets a product for Oral Mucositis (OM) - a side effect of cancer treatment - and wanted to better understand the disease and treatment challenges faced by both...

How integrated insights supported a biologic launch strategy across multiple indications

Our client is launching a new biologic in dermatology across indications and needed to understand the market, including the patient pool, treatment landscape, potential uptake and pricing opportunity for their...

How a hybrid approach delivered fast insights to feed into an oncology product’s adoption strategy

Our client wanted to quantify how ovarian cancer patients are managed prior to product launch, but also needed to understand why patients do or do not receive key diagnostic tests...